Company Filing History:
Years Active: 2021-2024
Title: Devan V Mehrotra: Innovator in Genetic Markers
Introduction
Devan V Mehrotra is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of genetics, particularly in identifying genetic markers that can enhance treatment responses for various medical conditions. With a total of 2 patents, his work is paving the way for more personalized medical therapies.
Latest Patents
One of Mehrotra's latest patents focuses on "Human genetic markers associated with response to treatments that target clostridium difficile toxin B." This invention provides genetic markers located on human chromosome 6 that are linked to a beneficial response to treatments targeting toxin B (TcdB), such as TcdB antibodies. These markers are instrumental in identifying patients who are likely to benefit from such treatments, thereby improving therapeutic outcomes. Additionally, the invention includes antibodies, drug products, and kits that utilize these TcdB treatment response markers.
Another significant patent by Mehrotra is titled "Genetic markers associated with response to CRTH2 receptor antagonists." This invention identifies genetic markers on human chromosome 1 that correlate with a positive response to CRTH2 receptor antagonists. These markers are valuable for determining which patients are most likely to benefit from treatments involving CRTH2 receptor antagonist compositions, thus aiding in the selection of the most appropriate therapies.
Career Highlights
Throughout his career, Devan V Mehrotra has worked with prominent organizations such as Merck Sharp & Dohme Corporation and the Beijing Genomics Institute at Shenzhen. His experience in these leading companies has contributed to his expertise in genetic research and innovation.
Collaborations
Mehrotra has collaborated with notable colleagues, including Peter M Shaw and Rebecca L Blanchard. These partnerships have likely enhanced his research capabilities and broadened the impact of his inventions.
Conclusion
Devan V Mehrotra is a distinguished inventor whose work in genetic markers is making significant strides in personalized medicine. His patents not only advance scientific understanding but also hold the potential to improve patient care through targeted therapies.